IOVA

6.9005.61%
CY

Cassian Yee

Member of Scientific Advisory Board

Dr. Cassian Yee, M.D. is Founder & Director of Mongoose Bio, Inc. and served as its President. Dr. Yee is Member of Scientific Advisory Council of Cancer Research Institute, Inc. He was a Member of Scientific Advisory Board of Obsidian Therapeutics, Inc. He serves as President & Director at Mongoose Bio, Inc. Dr. Yee serves as a Member of Scientific Advisory Board at Gadeta B.V., since October 2022. He serves as Member of Scientific Advisory Board at Immatics N.V. Dr. Yee is a Professor of Department of Immunology, Division of Cancer Medicine and Director of Solid Tumor Cell Therapy, Center for Cancer Immunology Research at the University of Texas MD Anderson Cancer Center. Dr. Yee is Professor of Department of Melanoma Medical Oncology, Division of Cancer Medicine at the University of Texas MD Anderson Cancer. He has been Member of Scientific Advisory Board at RootPath Genomics, Inc. Dr. Yee was Professor in Division of Oncology at the University of Washington. Dr. Yee serves as a Member of Scientific Advisory Board at Iovance Biotherapeutics, Inc. (formerly known as Lion Biotechnologies, Inc.) He is on the cutting edge adoptive immunotherapy which is one of many unexpected breakthroughs to emerge from the bone-marrow transplantation treatments pioneered by the Hutchinson Center’s Dr. E. Donnall Thomas to cure leukemia and other blood cancers. His research was among the first to show that adoptive T-cell therapy holds great promise for treating melanoma, a potentially fatal form of skin cancer. In recognition of the potential for his research, Dr. Yee received a prestigious five-year grant from the Burroughs Wellcome Fund in 2006 to refine the therapy and improve its tumor-fighting ability. Dr. Yee serves as a Member of Scientific Advisory Board at Adaptive Biotechnologies Corporation. He served as Scientific Advisor at GT Biopharma, Inc. (a/k/a OXIS International, Inc.) until December 2017. He is a Member of Scientific Advisory Board at AffyImmune Therapeutics, Inc. He is a Member of the American Association for Cancer Research, the American Association of Immunologists and the Society for Biological Therapy. He was a Member in the Department of Immunology, Clinical Research Division of the Fred Hutchinson Cancer Research Center. His research has won various awards including the Burroughs Wellcome Fund Career Award, the Cancer Research Institute Investigator Award, the Cancer Research Institute Melanoma Initiative Clinical Trials Grant, the Howard Hughes Medical Institute Pilot Research Grant and the Damon Runyon Walter Winchell (Eli Lilly) Clinical Investigator Award. He Is An Elected Member of The American Society of Clinical Investigators, Recipient of Clinical Translational Scientist Award From Burroughs Wellcome Fund. Dr. Yee received his Doctor of Medicine from the University of Manitoba in Winnipeg, Canada and has gone on to evaluate immunotherapy methods of melanoma and ovarian cancers. He served as Member of Scientific Advisory Board of Torque Therapeutics Inc. He serves as Member of Scientific Advisory Board at Obsidian Therapeutics, Inc. He trained as a research fellow at the Ontario Cancer Institute in Toronto before continuing his medical residency at Stanford University. Dr. Yee completed his fellowship in medical oncology and postdoctoral research studies at the University of Washington and the Fred Hutchinson Cancer Research Center.

公司職務